Table 1. Diagnostic Utility of MR-proANP As Compared to BNP in the Biomarkers in Acute HF (BACH) Trial.
MR-proANP (>120 pmol/L) | BNP (>100 pg/mL) | |
---|---|---|
Sensitivity | 95.56% | 96.98% |
Specificity | 59.85% | 61.90% |
Adapted from: Maisel A, Mueller C, Nowak R, et al. Mid-region prohormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute HF) trail. J Am Coll Cardiol 2010;55:2062-76